Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axsome Therapeutics, Inc. | 47,140 | reported | 26 Feb 2026 | tx 62+1,850,755−572,061 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Feb 2026 | SALE | Axsome Therapeutics, Inc. | 25,000 | 161.11 USD | |
| 23 Feb 2026 | EXERCISE | Axsome Therapeutics, Inc. | 6,250 | 4.95 USD | |
| 23 Feb 2026 | EXERCISE | Axsome Therapeutics, Inc. | 6,250 | 0.00 USD | deriv |
| 20 Feb 2026 | EXERCISE | Axsome Therapeutics, Inc. | 12,485 | 4.95 USD | |
| 20 Feb 2026 | EXERCISE | Axsome Therapeutics, Inc. | 12,485 | 0.00 USD | deriv |
| 10 Feb 2026 | EXERCISE | Axsome Therapeutics, Inc. | 5,193 | 8.02 USD | |
| 10 Feb 2026 | EXERCISE | Axsome Therapeutics, Inc. | 5,193 | 0.00 USD | deriv |
| 08 Sept 2025 | PURCHASE | Axsome Therapeutics, Inc. | 287 | 127.30 USD | |
| 08 Sept 2025 | PURCHASE | Axsome Therapeutics, Inc. | 488 | 127.40 USD | |
| 08 Sept 2025 | PURCHASE | Axsome Therapeutics, Inc. | 800 | 127.20 USD | first after silence |
| 06 Jun 2025 | GRANT_AWARD | Axsome Therapeutics, Inc. | 1,429 | 0.00 USD | deriv |
| 06 Jun 2025 | GRANT_AWARD | Axsome Therapeutics, Inc. | 3,166 | 0.00 USD | deriv |
| 27 May 2025 | SALE | Axsome Therapeutics, Inc. | 3,750 | 105.47 USD | |
| 28 May 2025 | SALE | Axsome Therapeutics, Inc. | 3,750 | 103.43 USD | |
| 20 May 2025 | SALE | Axsome Therapeutics, Inc. | 3,000 | 107.49 USD | |
| 03 Jan 2025 | EXERCISE | Axsome Therapeutics, Inc. | 9,127 | 9.00 USD | |
| 03 Jan 2025 | EXERCISE | Axsome Therapeutics, Inc. | 9,127 | 0.00 USD | deriv |
| 19 Nov 2024 | EXERCISE | Axsome Therapeutics, Inc. | 33,410 | 5.94 USD | |
| 19 Nov 2024 | EXERCISE | Axsome Therapeutics, Inc. | 33,410 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | Axsome Therapeutics, Inc. | 5,799 | 0.00 USD | deriv |
| 28 May 2024 | SALE | Axsome Therapeutics, Inc. | 5,249 | 75.21 USD | |
| 29 May 2024 | SALE | Axsome Therapeutics, Inc. | 5,248 | 75.14 USD | |
| 15 Sept 2023 | SALE | Axsome Therapeutics, Inc. | 18,572 | 75.18 USD | |
| 15 Sept 2023 | EXERCISE | Axsome Therapeutics, Inc. | 11,016 | 3.67 USD | |
| 15 Sept 2023 | SALE | Axsome Therapeutics, Inc. | 11,016 | 75.19 USD |
2 purchases reported after at least 12 months of silence — most recent on 08 Sept 2025.